These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

553 related items for PubMed ID: 2482293

  • 1. Early events in the antiproliferative action of tumor necrosis factor are similar to the early events in epidermal growth factor growth stimulation.
    Donato NJ, Ince C, Rosenblum MG, Gallick GE.
    J Cell Biochem; 1989 Nov; 41(3):139-57. PubMed ID: 2482293
    [Abstract] [Full Text] [Related]

  • 2. Resistance of human cervical carcinoma cells to tumor necrosis factor correlates with their increased sensitivity to cisplatin: evidence of a role for DNA repair and epidermal growth factor receptor.
    Nishikawa K, Rosenblum MG, Newman RA, Pandita TK, Hittelman WN, Donato NJ.
    Cancer Res; 1992 Sep 01; 52(17):4758-65. PubMed ID: 1380890
    [Abstract] [Full Text] [Related]

  • 3. Epidermal growth factor receptor expression and function control cytotoxic responsiveness to tumor necrosis factor in ME-180 squamous carcinoma cells.
    Donato NJ, Yan DH, Hung MC, Rosenblum MG.
    Cell Growth Differ; 1993 May 01; 4(5):411-9. PubMed ID: 8518234
    [Abstract] [Full Text] [Related]

  • 4. Tumor necrosis factor regulates tyrosine phosphorylation on epidermal growth factor receptors in A431 carcinoma cells: evidence for a distinct mechanism.
    Donato NJ, Rosenblum MG, Steck PA.
    Cell Growth Differ; 1992 May 01; 3(5):259-68. PubMed ID: 1378752
    [Abstract] [Full Text] [Related]

  • 5. Positive and negative selection for tumor necrosis factor responsiveness reveals an inhibitory role for EGF receptor in TNF-induced antiproliferation.
    Nishikawa K, Rotbein J, Vijjeswarapu D, Owen-Schaub L, Rosenblum MG, Donato NJ.
    Lymphokine Cytokine Res; 1994 Feb 01; 13(1):37-45. PubMed ID: 8186323
    [Abstract] [Full Text] [Related]

  • 6. Cross talk of tumor necrosis factor-alpha and epidermal growth factor in human microvascular endothelial cells.
    Izumi H, Ono M, Ushiro S, Kohno K, Kung HF, Kuwano M.
    Exp Cell Res; 1994 Oct 01; 214(2):654-62. PubMed ID: 7523156
    [Abstract] [Full Text] [Related]

  • 7. Effect of tumor necrosis factor-alpha on the phosphorylation of tyrosine kinase receptors is associated with dynamic alterations in specific protein-tyrosine phosphatases.
    Ahmad F, Goldstein BJ.
    J Cell Biochem; 1997 Jan 01; 64(1):117-27. PubMed ID: 9015760
    [Abstract] [Full Text] [Related]

  • 8. Differential expression and translocation of protein tyrosine phosphatase 1B-related proteins in ME-180 tumor cells expressing apoptotic sensitivity and resistance to tumor necrosis factor: potential interaction with epidermal growth factor receptor.
    Perez M, Haschke B, Donato NJ.
    Oncogene; 1999 Jan 28; 18(4):967-78. PubMed ID: 10023672
    [Abstract] [Full Text] [Related]

  • 9. Quantitative dissociation between EGF effects on c-myc and c-fos gene expression, DNA synthesis, and epidermal growth factor receptor tyrosine kinase activity.
    Hauguel-DeMouzon S, Csermely P, Zoppini G, Kahn CR.
    J Cell Physiol; 1992 Jan 28; 150(1):180-7. PubMed ID: 1730782
    [Abstract] [Full Text] [Related]

  • 10. Epidermal growth factor-induced apoptosis in A431 cells can be reversed by reducing the tyrosine kinase activity.
    Gulli LF, Palmer KC, Chen YQ, Reddy KB.
    Cell Growth Differ; 1996 Feb 28; 7(2):173-8. PubMed ID: 8822200
    [Abstract] [Full Text] [Related]

  • 11. Modulation of the cytotoxic activity of tumor necrosis factor by protein tyrosine kinase and protein tyrosine phosphatase inhibitors.
    Mishra S, Mathur R, Hamburger AW.
    Lymphokine Cytokine Res; 1994 Apr 28; 13(2):77-83. PubMed ID: 8061118
    [Abstract] [Full Text] [Related]

  • 12. Tumor necrosis factor stimulates ornithine decarboxylase activity in human fibroblasts and tumor target cells.
    Donato NJ, Rotbein J, Rosenblum MG.
    J Cell Biochem; 1991 May 28; 46(1):69-77. PubMed ID: 1874802
    [Abstract] [Full Text] [Related]

  • 13. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
    Ram TG, Ethier SP.
    Cell Growth Differ; 1996 May 28; 7(5):551-61. PubMed ID: 8732665
    [Abstract] [Full Text] [Related]

  • 14. Oncostatin M-specific receptor mediates inhibition of breast cancer cell growth and down-regulation of the c-myc proto-oncogene.
    Liu J, Spence MJ, Wallace PM, Forcier K, Hellström I, Vestal RE.
    Cell Growth Differ; 1997 Jun 28; 8(6):667-76. PubMed ID: 9186000
    [Abstract] [Full Text] [Related]

  • 15. IL-1 and TNF transmodulate epidermal growth factor receptors by a protein kinase C-independent mechanism.
    Bird TA, Saklatvala J.
    J Immunol; 1989 Jan 01; 142(1):126-33. PubMed ID: 2783320
    [Abstract] [Full Text] [Related]

  • 16. The expression of EGF receptors, EGF-like factors and c-myc in ovarian and cervical carcinomas and their potential clinical significance.
    Kohler M, Janz I, Wintzer HO, Wagner E, Bauknecht T.
    Anticancer Res; 1989 Jan 01; 9(6):1537-47. PubMed ID: 2697181
    [Abstract] [Full Text] [Related]

  • 17. Induction of met proto-oncogene (hepatocyte growth factor receptor) expression during human monocyte-macrophage differentiation.
    Chen Q, DeFrances MC, Zarnegar R.
    Cell Growth Differ; 1996 Jun 01; 7(6):821-32. PubMed ID: 8780895
    [Abstract] [Full Text] [Related]

  • 18. Effects of tumor necrosis factor and epidermal growth factor on cell morphology, cell surface receptors, and the production of tissue inhibitor of metalloproteinases and IL-6 in human microvascular endothelial cells.
    Mawatari M, Kohno K, Mizoguchi H, Matsuda T, Asoh K, Van Damme J, Welgus HG, Kuwano M.
    J Immunol; 1989 Sep 01; 143(5):1619-27. PubMed ID: 2547871
    [Abstract] [Full Text] [Related]

  • 19. Tumor necrosis factor modulates epidermal growth factor receptor phosphorylation and kinase activity in human tumor cells. Correlation with cytotoxicity.
    Donato NJ, Gallick GE, Steck PA, Rosenblum MG.
    J Biol Chem; 1989 Dec 05; 264(34):20474-81. PubMed ID: 2555361
    [Abstract] [Full Text] [Related]

  • 20. Blockade of the epidermal growth factor receptor tyrosine kinase activity by quercetin and luteolin leads to growth inhibition and apoptosis of pancreatic tumor cells.
    Lee LT, Huang YT, Hwang JJ, Lee PP, Ke FC, Nair MP, Kanadaswam C, Lee MT.
    Anticancer Res; 2002 Dec 05; 22(3):1615-27. PubMed ID: 12168845
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.